Clinical trial
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 is registered in ClinicalTrials.gov with Shixuan Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Mechanism Study of Uterine Sarcoma
- Lead sponsor
- Shixuan Wang
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2023
- Completion date
- November 30, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uterine sarcoma